GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Celgene Corporation (CELG) [hlAlert]

Rating:
Buy CELG
up 52.94 %

Celgene Corporation (CELG) rated Buy with price target $209 by UBS

Posted on: Thursday,  Feb 27, 2014  11:25 AM ET by UBS

UBS rated Buy Celgene Corporation (NASDAQ: CELG) on 02/27/2014, when the stock price was $80.45. Since
then, Celgene Corporation has gained 52.95% as of 01/14/2016's recent price of $123.04.
If you would have followed this UBS's recommendation on CELG, you would have gained 52.94% of your investment in 686 days.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/27/2014 11:25 AM Buy
None
80.45 104.50
as of 10/17/2014
1 Week down  -3.09 %
1 Month down  -4.48 %
3 Months up  6.00 %
1 YTD up  4.30 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/5/2013 12:25 PM Buy
None
82.55 100.00
9/10/2012 12:25 PM Hold
None
36.69 40.00
6/22/2012 11:25 AM Buy
None
30.44 39.00
4/27/2012 11:25 AM Buy
None
36.47 42.50
10/28/2011 10:25 AM Buy
None
33.01 37.50
7/29/2011 10:25 AM Buy
None
29.68 35.50
11/16/2010 10:25 AM Buy
None
30.29 34.50
4/1/2009 12:25 PM Buy
None
18.46 34.50
1/13/2009 1:25 PM Buy
None
25.28 37.50
10/15/2007 11:25 AM Buy
None
36.23 42.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy